Publication: Comparison of 5-Year Treatment Outcomes Between Alemtuzumab Versus Natalizumab, Fingolimod and Interferon Beta-1a
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
…
Description
32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -- SEP 14-17, 2016 -- London, ENGLAND
Keywords
Citation
WoS Q
Scopus Q
Source
Volume
22
Issue
Start Page
829
End Page
832